(Q46716170)

English

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function

scientific article published on 13 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

author name string

Jahyang Choi

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Beomseok Suh

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Yong-Oon Ahn

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Tae Min Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Jeong-Ok Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Se-Hoon Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Dae Seog Heo

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

publication date

13 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

33

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

121-129

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

https://scigraph.springernature.com/pub.10.1007/s13277-011-0254-6

0 references

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Regulation of immune responses by L-arginine metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Myeloid-derived suppressor cell heterogeneity and subset definition.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0254-6

21 January 2018

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil apoptosis is delayed in patients with inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delay of neutrophil apoptosis can exacerbate inflammation in sepsis patients: cellular mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung myeloid-derived suppressor cells and regulation of inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development

1 reference

https://pubmed.ncbi.nlm.nih.gov/22081309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-011-0254-6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22081309

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46716170&oldid=2127998346"